Can a smartphone app ease the burden of multiple myeloma?
NCT ID NCT06073353
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests a mobile app called THRIVE-M designed to help people with multiple myeloma cope with symptoms, emotions, and relationships. About 120 patients will either use the app or receive usual care. Researchers will measure whether the app improves quality of life, reduces distress, and lessens fatigue after 8 weeks.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
THRIVE-M mobile application (psychosocial support program)
What this could lead to
If it works, this app could offer a simple, at-home way to help multiple myeloma patients feel better emotionally and physically during treatment.
What could go wrong
This is a small, early-stage trial testing a behavioral intervention, not a drug. The app may not provide significant benefits over usual care, and results may not apply to all patients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE MYELOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Massachusetts General Hospital
Boston, Massachusetts, 02115, United States